Surgery Partners, Inc. (SGRY)
| Previous Close | 25.60 |
| Open | 27.50 |
| Bid | 27.92 x 300 |
| Ask | 28.05 x 300 |
| Day's Range | 27.00 - 28.55 |
| 52 Week Range | 22.05 - 45.79 |
| Volume | |
| Avg. Volume | 912,349 |
| Market Cap | 3.556B |
| Beta (5Y Monthly) | 2.74 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.09 |
| Earnings Date | May 07, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 42.36 |
- GuruFocus.com
Surgery Partners Inc (SGRY) Q1 2024 Earnings: Revenue and EBITDA Surpass Expectations, ...
Insights into Surgery Partners Inc's First Quarter Financials and Strategic Achievements
ZacksSurgery Partners (SGRY) Q1 Earnings and Revenues Beat Estimates
Surgery Partners (SGRY) delivered earnings and revenue surprises of 42.86% and 1.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswireSurgery Partners, Inc. Announces First Quarter 2024 Results
Raises Full Year 2024 GuidanceBRENTWOOD, Tenn., May 07, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the first quarter ended March 31, 2024. Revenues increased 7.7% to $717.4 million compared to the prior year period Same-facility revenues increased 10.2% Net loss attributable to Surgery Partners, Inc. was $12.4 million Adjusted EBITDA was $97.5 million,
